Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $493.22 ($4.7M) on 2026-09-17, disclosed to the SEC on 2026-09-18.
Scheduled sale ($4.7M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $493.22 | 599 | $295K | 6.3% |
| 2 | $494.34 | 1,750 | $865K | 18.4% |
| 3 | $495.11 | 1,905 | $943K | 20.0% |
| 4 | $496.21 | 2,182 | $1.1M | 23.0% |
| 5 | $497.17 | 1,953 | $971K | 20.6% |
| 6 | $497.79 | 151 |
| $75K |
| 1.6% |
| 7 | $499.10 | 332 | $166K | 3.5% |
| 8 | $500.09 | 468 | $234K | 5.0% |
| 9 | $501.60 | 160 | $80K | 1.7% |
| Total | $496.06 avg | 9,500 | $4.7M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-14 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |